Cabaletta Bio (CABA) Interest Coverage Ratio (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Interest Coverage Ratio came in at 9.95 in Q4 2025, up 122.03% year-on-year from 4.48 in Q4 2024, and up 573.1% quarter-over-quarter from 2.1 in Q3 2025.
Cabaletta Bio (CABA) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
Cabaletta Bio's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 9.95 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 122.03% year-over-year to 9.95 in Q4 2025; TTM through Dec 2025 was 206.52, a 669.2% increase from a year earlier, with the FY2025 full-year figure at 1.09, up 3.45% from the prior year.
- Interest Coverage Ratio advanced to 9.95 in Q4 2025 per CABA's latest filing, from 2.1 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 110.75 in Q4 2023 and bottomed at 5869.46 in Q4 2021.
- The 5-year median for Interest Coverage Ratio is 1.33 (2021), against an average of 291.61.
- Across the five-year window, Interest Coverage Ratio plunged 1193796.22% in 2021 and surged 2076.89% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 5869.46 in 2021, then jumped by 99.9% to 5.6 in 2022, then jumped by 2076.89% to 110.75 in 2023, then sank by 140.78% to 45.17 in 2024, then surged by 122.03% to 9.95 in 2025.
- Per Business Quant, the three latest CABA Interest Coverage Ratio figures stand at 9.95 (Q4 2025), 2.1 (Q3 2025), and 10.05 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | 9.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.95 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -10.05 |
| Mar 31, 2025 | -6.78 |
| Dec 31, 2024 | -45.17 |
| Sep 30, 2024 | -2.17 |
| Jun 30, 2024 | -2.26 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | 110.75 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -5.60 |
| Sep 30, 2022 | -1.90 |
| Jun 30, 2022 | -1.34 |
| Mar 31, 2022 | -1.24 |
| Dec 31, 2021 | -5,869.46 |
| Sep 30, 2021 | -0.70 |
| Jun 30, 2021 | -1.32 |
| Mar 31, 2021 | -0.74 |